Sevoflurane induces tau phosphorylation and glycogen synthase kinase 3β activation in young mice

Anesthesiology

Volumn 121, Issue 3, 2014, Pages 510-527

  Tao, Guorong ^a,b   Zhang, Jie ^a,c   Zhang, Lei ^a,d   Dong, Yuanlin ^a   Yu, Buwei ^b   Crosby, Gregory ^e   Culley, Deborah J ^e   Zhang, Yiying ^a   Xie, Zhongcong ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; INTERLEUKIN 6; LITHIUM; POSTSYNAPTIC DENSITY PROTEIN 95; SEVOFLURANE; TAU PROTEIN; ETHER DERIVATIVE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; INHALATION ANESTHETIC AGENT;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; BODY WEIGHT; COGNITION; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIPPOCAMPUS; MALE; MORRIS WATER MAZE TEST; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; SYNAPSE; WESTERN BLOTTING; AGING; ANIMAL; BLOOD; C57BL MOUSE; CHEMICALLY INDUCED; DRUG EFFECTS; ESCAPE BEHAVIOR; METABOLISM; PHOSPHORYLATION;

AGING; ANESTHETICS, INHALATION; ANIMALS; COGNITION DISORDERS; ENZYME ACTIVATION; ESCAPE REACTION; FEMALE; GLYCOGEN SYNTHASE KINASE 3; HIPPOCAMPUS; INTERLEUKIN-6; LITHIUM; MALE; METHYL ETHERS; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; TAU PROTEINS;

EID: 84921691623     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000000278     Document Type: Article

References (75)

1. Wilder RT, Flick RP, Sprung J, Katusic SK, Barbaresi WJ, Mickelson C, Gleich SJ, Schroeder DR, Weaver AL, Warner DO: Early exposure to anesthesia and learning disabilities in a population-based birth cohort. Anesthesiology 2009; 110:796-804.
2. Flick RP, Katusic SK, Colligan RC, Wilder RT, Voigt RG, Olson MD, Sprung J, Weaver AL, Schroeder DR, Warner DO: Cognitive and behavioral outcomes after early exposure to anesthesia and surgery. Pediatrics 2011; 128:e1053-61.
3. Sun L: Early childhood general anaesthesia exposure and neurocognitive development. Br J Anaesth 2010; 105(suppl 1):i61-8.
4. Jevtovic-Todorovic V, Hartman RE, Izumi Y, Benshoff ND, Dikranian K, Zorumski CF, Olney JW, Wozniak DF: Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci 2003; 23:876-82.
5. Satomoto M, Satoh Y, Terui K, Miyao H, Takishima K, Ito M, Imaki J: Neonatal exposure to sevoflurane induces abnormal social behaviors and deficits in fear conditioning in mice. Anesthesiology 2009; 110:628-37.
6. Stratmann G, Sall JW, May LD, Bell JS, Magnusson KR, Rau V, Visrodia KH, Alvi RS, Ku B, Lee MT, Dai R: Isoflurane differentially affects neurogenesis and long-term neurocognitive function in 60-day-old and 7-day-old rats. Anesthesiology 2009; 110:834-48.
7. Brambrink AM, Back SA, Riddle A, Gong X, Moravec MD, Dissen GA, Creeley CE, Dikranian KT, Olney JW: Isoflurane induced apoptosis of oligodendrocytes in the neonatal primate brain. Ann Neurol 2012; 72:525-35.
8. Brambrink AM, Evers AS, Avidan MS, Farber NB, Smith DJ, Zhang X, Dissen GA, Creeley CE, Olney JW: Isofluraneinduced neuroapoptosis in the neonatal rhesus macaque brain. Anesthesiology 2010; 112:834-41.
9. Shen X, Dong Y, Xu Z, Wang H, Miao C, Soriano SG, Sun D, Baxter MG, Zhang Y, Xie Z: Selective anesthesia-induced neuroinflammation in developing mouse brain and cognitive impairment. Anesthesiology 2013; 118:502-15.
10. Grundke-Iqbal I, Iqbal K, Quinlan M, Tung YC, Zaidi MS, Wisniewski HM: Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem 1986; 261:6084-9.
11. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI : Abnormal phosphorylation of the microtubule- Associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A 1986; 83:4913-7.
12. Trojanowski JQ, Lee VM: Paired helical filament tau in Alzheimer's disease. The kinase connection. Am J Pathol 1994; 144:449-53.
13. Buée L, Bussière T, Buée-Scherrer V, Delacourte A, Hof PR: Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev 2000; 33:95-130.
14. Small SA, Duff K: Linking Abeta and tau in late-onset Alzheimer's disease: A dual pathway hypothesis. Neuron 2008; 60:534-42.
15. Querfurth HW, LaFerla FM: Alzheimer's disease. N Engl J Med 2010; 362:329-44.
16. Huang Y, Mucke L: Alzheimer mechanisms and therapeutic strategies. Cell 2012; 148:1204-22.
17. Sheng M, Sabatini BL, Südhof TC: Synapses and Alzheimer's disease. Cold Spring Harb Perspect Biol 2012; 4:a005777.
18. Buée L, Troquier L, Burnouf S, Belarbi K, Van der Jeugd A, Ahmed T, Fernandez-Gomez F, Caillierez R, Grosjean ME, Begard S, Barbot B, Demeyer D, Obriot H, Brion I, Buée- Scherrer V, Maurage CA, Balschun D, D'hooge R, Hamdane M, Blum D, Sergeant N: From tau phosphorylation to tau aggregation: What about neuronal death? Biochem Soc Trans 2010; 38:967-72.
19. Iqbal K, Liu F, Gong CX, Grundke-Iqbal I: Tau in Alzheimer disease and related tauopathies. Curr Alzheimer Res 2010; 7:656-64.
20. Tan W, Cao X, Wang J, Lv H, Wu B, Ma H: Tau hyperphosphorylation is associated with memory impairment after exposure to 1.5% isoflurane without temperature maintenance in rats. Eur J Anaesthesiol 2010; 27:835-41.
21. Van der Jeugd A, Ahmed T, Burnouf S, Belarbi K, Hamdame M, Grosjean ME, Humez S, Balschun D, Blum D, Buée L, D'Hooge R: Hippocampal tauopathy in tau transgenic mice coincides with impaired hippocampus-dependent learning and memory, and attenuated late-phase long-term depression of synaptic transmission. Neurobiol Learn Mem 2011; 95:296-304.
22. Polydoro M, Acker CM, Duff K, Castillo PE, Davies P: Agedependent impairment of cognitive and synaptic function in the htau mouse model of tau pathology. J Neurosci 2009; 29:10741-9.
23. Kimura T, Yamashita S, Fukuda T, Park JM, Murayama M, Mizoroki T, Yoshiike Y, Sahara N, Takashima A: Hyperphosphorylated tau in parahippocampal cortex impairs place learning in aged mice expressing wild-type human tau. EMBO J 2007; 26:5143-52.
24. Wang JZ, Wu Q, Smith A, Grundke-Iqbal I, Iqbal K: Tau is phosphorylated by GSK-3 at several sites found in Alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by A-kinase. FEBS Lett 1998; 436:28-34.
25. Liu F, Iqbal K, Grundke-Iqbal I, Gong CX: Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3β. FEBS Lett 2002; 530:209-14.
26. Johnson GV, Hartigan JA: Tau protein in normal and Alzheimer's disease brain: An update. J Alzheimers Dis 1999; 1:329-51.
27. Godemann R, Biernat J, Mandelkow E, Mandelkow EM: Phosphorylation of tau protein by recombinant GSK-3β: Pronounced phosphorylation at select Ser/Thr-Pro motifs but no phosphorylation at Ser262 in the repeat domain. FEBS Lett 1999; 454:157-64.
28. Pei JJ, Grundke-Iqbal I, Iqbal K, Bogdanovic N, Winblad B, Cowburn RF: Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration. Brain Res 1998; 797:267-77.
29. Pei JJ, Braak E, Braak H, Grundke-Iqbal I, Iqbal K, Winblad B, Cowburn RF: Localization of active forms of C-jun kinase ( JNK) and p38 kinase in Alzheimer's disease brains at different stages of neurofibrillary degeneration. J Alzheimers Dis 2001; 3:41-8.
30. Yoshida H, Hastie CJ, McLauchlan H, Cohen P, Goedert M: Phosphorylation of microtubule-associated protein tau by isoforms of c-Jun N-terminal kinase ( JNK). J Neurochem 2004; 90:352-8.
31. Wang JZ, Liu F: Microtubule-associated protein tau in development, degeneration and protection of neurons. Prog Neurobiol 2008; 85:148-75.
32. Wang JZ, Xia YY, Grundke-Iqbal I, Iqbal K: Abnormal hyperphosphorylation of tau: Sites, regulation, and molecular mechanism of neurofibrillary degeneration. J Alzheimers Dis 2013; 33(suppl 1):S123-39.
33. Whittington RA, Bretteville A, Dickler MF, Planel E: Anesthesia and tau pathology. Prog Neuropsychopharmacol Biol Psychiatry 2013; 47:147-55.
34. Takahashi M, Tomizawa K, Ishiguro K: Distribution of tau protein kinase I/glycogen synthase kinase-3β, phosphatases 2A and 2B, and phosphorylated tau in the developing rat brain. Brain Res 2000; 857:193-206.
35. Goedert M, Cohen ES, Jakes R, Cohen P: p42 MAP kinase phosphorylation sites in microtubule-associated protein tau are dephosphorylated by protein phosphatase 2A1. Implications for Alzheimer's disease [corrected]. FEBS Lett 1992; 312:95-9.
36. Wang JZ, Grundke-Iqbal I, Iqbal K: Restoration of biological activity of Alzheimer abnormally phosphorylated tau by dephosphorylation with protein phosphatase-2A, -2B and -1. Brain Res Mol Brain Res 1996; 38:200-8.
37. Gong CX, Shaikh S, Grundke-Iqbal I, Iqbal K: Inhibition of protein phosphatase-2B (calcineurin) activity towards Alzheimer abnormally phosphorylated tau by neuroleptics. Brain Res 1996; 741:95-102.
38. Gong CX, Shaikh S, Wang JZ, Zaidi T, Grundke-Iqbal I, Iqbal K: Phosphatase activity toward abnormally phosphorylated tau: Decrease in Alzheimer disease brain. J Neurochem 1995; 65:732-8.
39. Mawal-Dewan M, Henley J, Van de Voorde A, Trojanowski JQ, Lee VM: The phosphorylation state of tau in the developing rat brain is regulated by phosphoprotein phosphatases. J Biol Chem 1994; 269:30981-7.
40. Planel E, Sun X, Takashima A: Role of GS K-3b in Alzheimer's disease pathology. Drug Development Research 2002; 56:491-10.
41. Planel E, Richter KE, Nolan CE, Finley JE, Liu L, Wen Y, Krishnamurthy P, Herman M, Wang L, Schachter JB, Nelson RB, Lau LF, Duff KE: Anesthesia leads to tau hyperphosphorylation through inhibition of phosphatase activity by hypothermia. J Neurosci 2007; 27:3090-7.
42. Planel E, Krishnamurthy P, Miyasaka T, Liu L, Herman M, Kumar A, Bretteville A, Figueroa HY, Yu WH, Whittington RA, Davies P, Takashima A, Nixon RA, Duff KE: Anesthesia induced hyperphosphorylation detaches 3-repeat tau from microtubules without affecting their stability in vivo. J Neurosci 2008; 28:12798-807.
43. Planel E, Bretteville A, Liu L, Virag L, Du AL, Yu WH, Dickson DW, Whittington RA, Duff KE: Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia. FASEB J 2009; 23:2595-604.
44. Dong Y, Wu X, Xu Z, Zhang Y, Xie Z: Anesthetic isoflurane increases phosphorylated tau levels mediated by caspase activation and Aβ generation. PLoS One 2012; 7:e39386.
45. Le Freche H, Brouillette J, Fernandez-Gomez FJ, Patin P, Caillierez R, Zommer N, Sergeant N, Buée-Scherrer V, Lebuffe G, Blum D, Buée L: Tau phosphorylation and sevoflurane anesthesia: An association to postoperative cognitive impairment. Anesthesiology 2012; 116:779-87.
46. Whittington RA, Virág L, Marcouiller F, Papon MA, El Khoury NB, Julien C, Morin F, Emala CW, Planel E: Propofol directly increases tau phosphorylation. PLoS One 2011; 6:e16648.
47. Takeuchi M, Hata Y, Hirao K, Toyoda A, Irie M, Takai Y: SAPAPs. A family of PSD-95/SAP90-associated proteins localized at postsynaptic density. J Biol Chem 1997; 272:11943-51.
48. Liu Q, Trotter J, Zhang J, Peters MM, Cheng H, Bao J, Han X, Weeber EJ, Bu G: Neuronal LRP1 knockout in adult mice leads to impaired brain lipid metabolism and progressive, age-dependent synapse loss and neurodegeneration. J Neurosci 2010; 30:17068-78.
49. Hong M, Chen DC, Klein PS, Lee VM: Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3. J Biol Chem 1997; 272:25326-32.
50. Lu Y, Wu X, Dong Y, Xu Z, Zhang Y, Xie Z: Anesthetic sevoflurane causes neurotoxicity differently in neonatal naïve and Alzheimer disease transgenic mice. Anesthesiology 2010; 112:1404-16.
51. Kakefuda K, Oyagi A, Ishisaka M, Tsuruma K, Shimazawa M, Yokota K, Shirai Y, Horie K, Saito N, Takeda J, Hara H: Diacylglycerol kinase β knockout mice exhibit lithium-sensitive behavioral abnormalities. PLoS One 2010; 5:e13447.
52. Bianchi SL, Tran T, Liu C, Lin S, Li Y, Keller JM, Eckenhoff RG, Eckenhoff MF: Brain and behavior changes in 12-monthold Tg2576 and nontransgenic mice exposed to anesthetics. Neurobiol Aging 2008; 29:1002-10.
53. Xie Z, Culley DJ, Dong Y, Zhang G, Zhang B, Moir RD, Frosch MP, Crosby G, Tanzi RE: The common inhalation anesthetic isoflurane induces caspase activation and increases amyloid β-protein level in vivo. Ann Neurol 2008; 64:618-27.
54. Cross DA, Alessi DR, Vandenheede JR, McDowell HE, Hundal HS, Cohen P: The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: Evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf. Biochem J 1994; 303(Pt 1): 21-6.
55. Sutherland C, Leighton IA, Cohen P: Inactivation of glycogen synthase kinase-3β by phosphorylation: New kinase connections in insulin and growth-factor signalling. Biochem J 1993; 296(Pt 1):15-9.
56. Stambolic V, Woodgett JR: Mitogen inactivation of glycogen synthase kinase-3β in intact cells via serine 9 phosphorylation. Biochem J 1994; 303(Pt 3):701-4.
57. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA: Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995; 378:785-9.
58. Jope RS, Johnson GV: The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci 2004; 29:95-102.
59. Ougolkov AV, Billadeau DD: Targeting GS K-3: A promising approach for cancer therapy? Future Oncol 2006; 2:91-100.
60. Lei P, Ayton S, Bush AI, Adlard PA: GS K-3 in neurodegenerative diseases. Int J Alzheimers Dis 2011; 2011:189246.
61. Braida D, Sacerdote P, Panerai AE, Bianchi M, Aloisi AM, Iosuè S, Sala M: Cognitive function in young and adult IL (interleukin)- 6 deficient mice. Behav Brain Res 2004; 153:423-9.
62. Cao XZ, Ma H, Wang JK, Liu F, Wu BY, Tian AY, Wang LL, Tan WF: Postoperative cognitive deficits and neuroinflammation in the hippocampus triggered by surgical trauma are exacerbated in aged rats. Prog Neuropsychopharmacol Biol Psychiatry 2010; 34:1426-32.
63. Huang Y, Henry CJ, Dantzer R, Johnson RW, Godbout JP: Exaggerated sickness behavior and brain pro inflammatory cytokine expression in aged mice in response to intra cerebroventricular lipopolysaccharide. Neurobiol Aging 2008; 29:1744-53.
64. Patanella AK, Zinno M, Quaranta D, Nociti V, Frisullo G, Gainotti G, Tonali PA, Batocchi AP, Marra C: Correlations between peripheral blood mononuclear cell production of BDNF, TNF-α, IL -6, IL -10 and cognitive performances in multiple sclerosis patients. J Neurosci Res 2010; 88:1106-12.
65. Hudetz JA, Gandhi SD, Iqbal Z, Patterson KM, Pagel PS: Elevated postoperative inflammatory biomarkers are associated with short- And medium-term cognitive dysfunction after coronary artery surgery. J Anesth 2011; 25:1-9.
66. Schuitemaker A, Dik MG, Veerhuis R, Scheltens P, Schoonenboom NS, Hack CE, Blankenstein MA, Jonker C: Inflammatory markers in AD and MCI patients with different biomarker profiles. Neurobiol Aging 2009; 30:1885-9.
67. Carter L, Zolezzi M, Lewczyk A: An updated review of the optimal lithium dosage regimen for renal protection. Can J Psychiatry 2013; 58:595-600.
68. Asai H, Ikezu S, Woodbury ME, Yonemoto GM, Cui L, Ikezu T: Accelerated neurodegeneration and neuroinflammation in transgenic mice expressing P301L tau mutant and tau-tubulin kinase 1. Am J Pathol 2014; 184:808-18.
69. Bellucci A, Westwood AJ, Ingram E, Casamenti F, Goedert M, Spillantini MG: Induction of inflammatory mediators and microglial activation in mice transgenic for mutant human P301S tau protein. Am J Pathol 2004; 165:1643-52.
70. Lee DC, Rizer J, Selenica ML, Reid P, Kraft C, Johnson A, Blair L, Gordon MN, Dickey CA, Morgan D: LPS-induced inflammation exacerbates phospho-tau pathology in rTg4510 mice. J Neuroinflammation 2010; 7:56.
71. Kitazawa M, Oddo S, Yamasaki TR, Green KN, LaFerla FM: Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. J Neurosci 2005; 25:8843-53.
72. Yoshiyama Y, Higuchi M, Zhang B, Huang SM, Iwata N, Saido TC, Maeda J, Suhara T, Trojanowski JQ, Lee VM: Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 2007; 53: 337-51.
73. Run X, Liang Z, Zhang L, Iqbal K, Grundke-Iqbal I, Gong CX: Anesthesia induces phosphorylation of tau. J Alzheimers Dis 2009; 16:619-26.
74. Zhang Y, Dong Y, Zheng H, Shie V, Wang H, Busscher JJ, Yue Y, Xu Z, Xie Z: Sevoflurane inhibits neurogenesis and the Wnt-catenin signaling pathway in mouse neural progenitor cells. Curr Mol Med 2013; 13:1446-54.
75. Wan Y, Xu J, Meng F, Bao Y, Ge Y, Lobo N, Vizcaychipi MP, Zhang D, Gentleman SM, Maze M, Ma D: Cognitive decline following major surgery is associated with gliosis, β-amyloid accumulation, and τ phosphorylation in old mice. Crit Care Med 2010; 38:2190-8.